
Sugarace PG 1mg/500mg/15mg Tablet PR
Marketer
Inavars Biologicals Inc
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Sugarace PG 1mg/500mg/15mg Tablet PR
Diabetace Trio 1mg/500mg/15mg tablets are a combined medication formulated to manage blood glucose. This treatment, used alongside a healthy diet and regular exercise, enhances glycemic control in adult patients with type 2 diabetes. It facilitates efficient insulin utilization, resulting in reduced blood sugar. Diabetace Trio should be administered precisely as prescribed by your physician, including dosage and duration. Taking it with food is recommended to minimize gastrointestinal discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume your usual schedule. Never double the dose. An overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may increase the risk of hypoglycemia. Regular blood glucose monitoring is crucial during treatment. Other potential side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating women should seek medical advice before using this medication. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption, as this can heighten the risk of certain adverse reactions.
Primary Ingredients of Sugarace PG 1mg/500mg/15mg Tablet PR
The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Sugarace PG 1mg/500mg/15mg Tablet PR
Managing Type 2 Diabetes
Major Benefits of Sugarace PG 1mg/500mg/15mg Tablet PR:
Follow your doctor's instructions or consult the product label for proper administration. Ingest Sugarace PG 1mg/500mg/15mg Tablet PR with a meal.
Common Side effects of Sugarace PG 1mg/500mg/15mg Tablet PR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Sugarace PG 1mg/500mg/15mg Tablet PR:
Follow your doctor's instructions or consult the product information leaflet for dosage guidance. Administer Sugarace PG 1mg/500mg/15mg Tablet PR with a meal.
How Sugarace PG 1mg/500mg/15mg Tablet PR works:
Sugarace PG tablets (1mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple combination enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Sugarace PG 1mg/500mg/15mg Tablet PR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Sugarace PG 1mg/500mg/15mg Tablet PR during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing it. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Sugarace PG 1mg/500mg/15mg Tablet PR while breastfeeding is likely inadvisable. Available evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Sugarace PG 1mg/500mg/15mg Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Sugarace PG 1mg/500mg/15mg Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Sugarace PG 1mg/500mg/15mg Tablet PR is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Sugarace PG 1mg/500mg/15mg Tablet PR :
Should you forget a Sugarace PG 1mg/500mg/15mg Tablet PR dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sugarace PG 1mg/500mg/15mg Tablet PR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
